Influenza Vaccination and Reduction in Hospitalizations for Cardiac Disease and Stroke among the Elderly
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Upper respiratory tract illnesses have been associated with an increased risk of ischemic heart disease and stroke. During two influenza seasons, we assessed the influence of vaccination against influenza on the risk of hospitalization for heart disease and stroke, hospitalization for pneumonia and influenza, and death from all causes. METHODS: Cohorts of community-dwelling members of three large managed-care organizations who were at least 65 years old were studied during the 1998-1999 and 1999-2000 influenza seasons. Administrative and clinical data were used to evaluate outcomes, with multivariable logistic regression to control for base-line demographic and health characteristics of the subjects. RESULTS: There were 140,055 subjects in the 1998-1999 cohort and 146,328 in the 1999-2000 cohort, of which 55.5 percent and 59.7 percent, respectively, were immunized. At base line, vaccinated subjects were on average sicker, having higher rates of most coexisting conditions, outpatient care, and prior hospitalization for pneumonia than unvaccinated subjects. Unvaccinated subjects, however, were more likely to have been given a prior diagnosis of dementia or stroke. Vaccination against influenza was associated with a reduction in the risk of hospitalization for cardiac disease (reduction of 19 percent during both seasons [P<0.001]), cerebrovascular disease (reduction of 16 percent during the 1998-1999 season [P<0.018] and 23 percent during the 1999-2000 season [P<0.001]), and pneumonia or influenza (reduction of 32 percent during the 1998-1999 season [P<0.001] and 29 percent during the 1999-2000 season [P<0.001]) and a reduction in the risk of death from all causes (reduction of 48 percent during the 1998-1999 season [P<0.001] and 50 percent during the 1999-2000 season [P<0.001]). In analyses according to age, the presence or absence of major medical conditions at base line, and study site, the findings were consistent across all subgroups. CONCLUSIONS: In the elderly, vaccination against influenza is associated with reductions in the risk of hospitalization for heart disease, cerebrovascular disease, and pneumonia or influenza as well as the risk of death from all causes during influenza seasons. These findings highlight the benefits of vaccination and support efforts to increase the rates of vaccination among the elderly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Influenza vaccination as a population-wide prevention measure was associated with a very cost-effective reduction in clinical events.171”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [171]
Citations
Cites
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010.
Schrag, S. D., Gorwitz, R. J., Fultz-Butts, K., & Schuchat, A. (2002) · PubMed · Cited by 3,349
The number needed to treat: a clinically useful measure of treatment effect
Cook, R. J., & Sackett, D. L. (1995) · BMJ · doi:10.1136/bmj.310.6977.452 · Cited by 1,885
Holtzman, D. J., Powell‐Griner, E., Bolen, J. C., & Rhodes, L. (2000) · PubMed · Cited by 1,110
Nichol, K. L., Margolis, K. L., Wuorenma, J., & Von Sternberg, T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311206 · Cited by 996
Self-citationInfection and Atherosclerosis: Emerging Mechanistic Paradigms
Epstein, S. E., Zhou, Y. F., & Zhu, J. (1999) · Circulation · doi:10.1161/01.cir.100.4.e20 · Cited by 511
Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.
Nichol, K. L., Wuorenma, J., & von Sternberg, T. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1769 · Cited by 484
Self-citationValidation of self-report of influenza and pneumococcal vaccination status in elderly outpatients
Mac Donald, R., Baken, L., Nelson, A., & Nichol, K. L. (1999) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(98)00159-7 · Cited by 410
Self-citationAcute respiratory-tract infections and risk of first-time acute myocardial infarction
Meier, C. R., Jick, S. S., Derby, L. E., Vasilakis, C., Jick, H., Meier, C., Jick, S., Derby, L., Vasilakis, C., & Jick, H. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11084-4 · Cited by 389
Vu, T., Farish, S., Jenkins, M., & Kelly, H. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00041-5 · Cited by 376
Research works printed but not linked: 7
- 2002, MMWR Morb Mortal Wkly Rep, 51, 1
- Nichol KL. Efficacy/clinical effectiveness of inactivated influenza virus vaccines in adults. In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of influenza. Oxford, England: Blackwell Science, 1998:358-72.
- Becher H, 2000, J Epidemiol Biostat, 5, 277
- 1999, MMWR Morb Mortal Wkly Rep, 48, 374
- 2000, MMWR Morb Mortal Wkly Rep, 49, 375
- 1997, MMWR Morb Mortal Wkly Rep, 46, 1
- Healthy People 2010: conference edition. Vol. 1. Washington, D.C.: Department of Health and Human Services, January 2000.
Cited by
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Mandell, L. A., Wunderink, R. G., Anzueto, A., Bartlett, J. G., Campbell, G. D., Dean, N. C., Dowell, S. F., File, T. M., Musher, D. M., Niederman, M. S., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/511159 · Cited by 6,202
“A recent large observational study of adults 65 years of age found that vaccination against influenza was associated with a reduction in the risk of hospitalization for cardiac disease (19% reduction), cerebrovascular disease (16%–23% reduction), and pneumonia or influenza (29%–32% reduction) and a reduction in the ri…”
Background2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510
Authors/Task Force Members, Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., Dallongeville, J., De Backer, G., Ebrahim, S., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,753
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
Dickstein, K., Authors/Task Force Members, Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Strömberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.08.005 · Cited by 3,512
“† Pneumoccocal vaccination and annual influenza vaccination should be considered in patients with symptomatic HF without known contraindications.(84)”
Authors/Task Force Members, Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn309 · Cited by 2,696
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Influenza-Associated Hospitalizations in the United States
Thompson, W. W. (2004) · JAMA · doi:10.1001/jama.292.11.1333 · Cited by 2,213
“Other studies also suggest that influenza virus activity is associated with an increase in hospitalizations for a broad range of cardiopulmonary diagnoses, and not just primary pneumoniaand influenzadischarges.(11,19)”
BackgroundGraham (2007) · doi:10.1097/01.hjr.0000277983.23934.c9 · Cited by 1,647
Authors/Task Force Members, Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316653709 · Cited by 1,334
Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306
Vaccination greatly reduces disease, disability, death and inequity worldwide
Andre, F., Booy, R., Bock, H., Clemens, J., Datta, S., John, T., Lee, B., Lolekha, S., Peltola, H., Ruff, T., et al. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.040089 · Cited by 1,234
Mandell, L. A., Bartlett, J. G., Dowell, S. F., File, T. M., Musher, D. M., & Whitney, C. (2003) · Clinical Infectious Diseases · doi:10.1086/380488 · Cited by 1,004
“death due to all causes (48%–50% reduction) [117].”
BackgroundAuthors/Task Force Members: Joep Perk (Chairperson) (Sweden)*, G. D. B. (. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312450228 · Cited by 863
Vaccines for preventing influenza in the elderly
Demicheli, V., Jefferson, T., Di Pietrantonj, C., Ferroni, E., Thorning, S., Thomas, R. E., & Rivetti, A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004876.pub4 · Cited by 695
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cifkova, R., et al. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.05.007 · Cited by 691
Effectiveness of Influenza Vaccine in the Community-Dwelling Elderly
Nichol, K. L., Nordin, J. D., Nelson, D. B., Mullooly, J. P., & Hak, E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070844 · Cited by 656
Self-citationRiegel, B., Moser, D. K., Buck, H. G., Dickson, V. V., Dunbar, S. B., Lee, C. S., Lennie, T. A., Lindenfeld, J., Mitchell, J. E., Treat‐Jacobson, D. J., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006997 · Cited by 620
“Other selfcare maintenance behaviors help reduce inflammation attributed to infection in CVD such as routine preventive dental care and annual influenza vaccination.(176,177) Medica-”
BackgroundEfficacy and effectiveness of influenza vaccines in elderly people: a systematic review
Jefferson, T., Rivetti, D., Rivetti, A., Rudin, M., Di Pietrantonj, C., & Demicheli, V (2005) · The Lancet · doi:10.1016/s0140-6736(05)67339-4 · Cited by 601
Innate Immune Function by Toll-like Receptors: Distinct Responses in Newborns and the Elderly
Kollmann, T. R., Levy, O., Montgomery, R. R., & Goriely, S. (2012) · Immunity · doi:10.1016/j.immuni.2012.10.014 · Cited by 565
“Indeed, the influence of genetic programs in early life can readily be identified in the strong influence of family history of atopy on lower IL-12p70 responses in infants suffering from allergy and asthma (Gabrielsson et al., 2001; Nilsson et al., 2004; van den Biggelaar et al., 2009).”
BackgroundManagement of Chronic Obstructive Pulmonary Disease
Sutherland, E. R., & Cherniack, R. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra030415 · Cited by 563
Schocken, D. D., Benjamin, E. J., Fonarow, G. C., Krumholz, H. M., Levy, D., Mensah, G. A., Narula, J., Shor, E. S., Young, J. B., & Hong, Y. (2008) · Circulation · doi:10.1161/circulationaha.107.188965 · Cited by 552
Impact of Influenza Vaccination on Seasonal Mortality in the US Elderly Population
(2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.3.265 · Cited by 543
“detrended series, Yt, excluding values for the period December to April: Yt=a+bcos(2 t /12)+csin(2 t /12)+et, where t is the index for month of death (1-408), and et is the error term.”
BackgroundPrina, E., Ranzani, O. T., & Torres, A. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60733-4 · Cited by 516
Udell, J. A., Zawi, R., Bhatt, D. L., Keshtkar-Jahromi, M., Gaughran, F., Phrommintikul, A., Ciszewski, A., Vakili, H., Hoffman, E. B., Farkouh, M. E., et al. (2013) · JAMA · doi:10.1001/jama.2013.279206 · Cited by 516
Evidence of bias in estimates of influenza vaccine effectiveness in seniors
Jackson, L. A., Jackson, M. L., Nelson, J. C., Neuzil, K. M., & Weiss, N. S. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyi274 · Cited by 493
Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019
Précoma, D. B., Oliveira, G. M. M. D., Simão, A. F., Dutra, O. P., Coelho-Filho, O. R., Izar, M. C. D. O., Póvoa, R. M. D. S., Giuliano, I. D. C. B., Alencar Filho, A. C. D., Machado, C. A., et al. (2019) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20190204 · Cited by 434
Role of acute infection in triggering acute coronary syndromes
Corrales-Medina, V. F., Madjid, M., & Musher, D. M. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70331-7 · Cited by 462
Xie, M., & Chen, Q. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.071 · Cited by 462
“Vaccination against influenza and Streptococcus pneumonia in vulnerable elderly people with comorbidities are highly cost-effective, which is demonstrated to associate with reductions in the risk of hospitalization and death from all causes during influenza seasons(Nichol et al., 2003).”
BackgroundJanssens, J.-P., & Krause, K.-H. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)00931-4 · Cited by 440
Kulik, A., Ruel, M., Jneid, H., Ferguson, T. B., Hiratzka, L. F., Ikonomidis, J. S., Lopez-Jimenez, F., McNallan, S. M., Patel, M., Roger, V. L., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000182 · Cited by 448
Influenza and the Winter Increase in Mortality in the United States, 1959-1999
Reichert, T. A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh227 · Cited by 451
“Influenza vaccination has been associated with large reductions in the risks of primary cardiac arrest (40), recurrent myocardial infarction (41), cardiac disease (42), and stroke (42, 43).”
BackgroundThe hidden burden of influenza: A review of the extra‐pulmonary complications of influenza infection
Sellers, S. A., Hagan, R. S., Hayden, F. G., & Fischer, W. A. (2017) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12470 · Cited by 438
Emergency department crowding and thrombolysis delays in acute myocardial infarction
Schull, M. J., Vermeulen, M., Slaughter, G., Morrison, L., & Daly, P. (2004) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.05.004 · Cited by 407
Contemporary Management of Chronic Obstructive Pulmonary Disease: Scientific Review
Sin, D. D., McAlister, F. A., Man, S. F. P., & Anthonisen, N. R. (2003) · JAMA · doi:10.1001/jama.290.17.2301 · Cited by 404
Prevention of hospital-associated pneumonia and ventilator-associated pneumonia
Kollef, M. H. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000128569.09113.fb · Cited by 366
The Cambridge Handbook of Age and Ageing
(2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511610714 · Cited by 336
Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, W. M. M., Albus, C., Benlian, P., Boysen, G., Cifkova, R., et al. (2012) · International Journal of Behavioral Medicine · doi:10.1007/s12529-012-9242-5 · Cited by 311
“Influenza vaccination as a population-wide prevention measure was associated with a very cost-effective reduction in clinical events.(171) Annual influenza vaccinations are recommended for patients with established CVD.”
Madjid, M., Miller, C. C., Zarubaev, V. V., Marinich, I. G., Kiselev, O. I., Lobzin, Y. V., Filippov, A. E., & Casscells, S. W. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm035 · Cited by 311
“[14] [15] [16] [17] [18] [19] [20] Interestingly, we found data supporting such an association in several old reports.”
Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline
Østergaard, L., Engedal, T. S., Moreton, F., Hansen, M. B., Wardlaw, J. M., Dalkara, T., Markus, H. S., & Muir, K. W. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15606723 · Cited by 283
Vaccines for preventing influenza in the elderly
Jefferson, T., Di Pietrantonj, C., Al-Ansary, L. A., Ferroni, E., Thorning, S., & Thomas, R. E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004876.pub3 · Cited by 253
Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke
Esenwa, C. C., & Elkind, M. S. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.125 · Cited by 281
Jackson, L. A., Nelson, J. C., Benson, P., Neuzil, K. M., Reid, R. J., Psaty, B. M., Heckbert, S. R., Larson, E. B., & Weiss, N. S. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyi275 · Cited by 281
Gurfinkel, E. (2004) · European Heart Journal · doi:10.1016/j.ehj.2003.10.018 · Cited by 268
Dushoff, J., Plotkin, J. B., Viboud, C., Earn, D. J. D., & Simonsen, L. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj024 · Cited by 259
Role of Viruses in Exacerbations of Chronic Obstructive Pulmonary Disease
Wedzicha, J. A. (2004) · Proceedings of the American Thoracic Society · doi:10.1513/pats.2306030 · Cited by 261
“A recent study of influenza immunization in older patients has shown that immunization is associated with a reduction in the risk of hospitalization for heart disease and stroke, thus providing more evidence for the link between respiratory viral infection and vascular disease (49).”
BackgroundHolland, D., Booy, R., Looze, F. D., Eizenberg, P., McDonald, J., Karrasch, J., McKeirnan, M., Salem, H., Mills, G., Reid, J., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/590434 · Cited by 254
Bakris, G. L., Fonseca, V., & Katholi, R. L. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2004.12.136 · Cited by 256
The virosome concept for influenza vaccines
Huckriede, A., Bungener, L., Stegmann, T., Daemen, T., Medema, J., Palache, A. M., & Wilschut, J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.026 · Cited by 250
Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence
Lang, P.-O., Mendes, Socquet, Assir, Govind, & Aspinall (2012) · Clinical Interventions in Aging · doi:10.2147/cia.s25215 · Cited by 245
“It is also the primary cause of increased mortality among patients with underlying chronic comorbid conditions (ie, acute ischemic heart disease, stroke, and pneumonia) in the winter season.(37,57,58) Serologic markers are a complex surrogate of influenza vaccine effectiveness, and notably when birth cohorts are compa…”
Cardiovascular manifestations associated with influenza virus infection
Mamas, M. A., Fraser, D., & Neyses, L. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.04.044 · Cited by 244
“[48] studied community-dwelling elderly subjects (288,238 persons ≥65 years old), in whom vaccination against influenza was associated with a 19% reduced risk of hospitalization for heart disease, 23% reduction in cerebrovascular disease and a 50% reduced all-cause mortality rate during influenza seasons.”
BackgroundThe Relationship between Lung Inflammation and Cardiovascular Disease
Van Eeden, S., Leipsic, J., Paul Man, S. F., & Sin, D. D. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0455pp · Cited by 226
McElhaney, J. E., Zhou, X., Talbot, H. K., Soethout, E., Bleackley, R. C., Granville, D. J., & Pawelec, G. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.015 · Cited by 229
“While annual vaccination is the mainstay of influenza management, it is apparent that current influenza vaccines are not keeping pace with the changing risk profile of an aging population [69–81].”
BackgroundInfluenza vaccines for preventing cardiovascular disease
Clar, C., Oseni, Z., Flowers, N., Keshtkar-Jahromi, M., & Rees, K. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005050.pub3 · Cited by 214
Tradeoffs between accuracy measures for electronic health care data algorithms
Chubak, J., Pocobelli, G., & Weiss, N. S. (2012) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.09.002 · Cited by 215
Influenza Vaccination and Mortality: Differentiating Vaccine Effects From Bias
Fireman, B., Lee, J., Lewis, N., Bembom, O., van der Laan, M., & Baxter, R. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp173 · Cited by 216
“(19, 24) reported that higher-risk patients were more likely to be vaccinated, Jackson et al.”
Viral Pneumonia in Older Adults
Falsey, A. R., & Walsh, E. E. (2006) · Clinical Infectious Diseases · doi:10.1086/499955 · Cited by 215
“In a study of nearly 300,000 communityliving elderly subjects, administration of trivalent inactivated virus vaccine was associated with 48%–50% reduction in the rate of deaths due to all causes and with significant reductions in rates of hospitalization for pneumonia and influenza, cardiac disease, and stroke, compar…”
ResultVaccines for preventing influenza in the elderly
Rivetti, D., Jefferson, T., Thomas, R. E., Rudin, M., Rivetti, A., Di Pietrantonj, C., & Demicheli, V. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004876.pub2 · Cited by 192
Acute Myocardial Infarction in Hospitalized Patients with Community‐Acquired Pneumonia
Ramirez, J., Aliberti, S., Mirsaeidi, M., Peyrani, P., Filardo, G., Amir, A., Moffett, B., Gordon, J., Blasi, F., & Bordon, J. (2008) · Clinical Infectious Diseases · doi:10.1086/589246 · Cited by 202
“and of hospitalization for cardiac events [7, 8].”
Innate immune signals in atherosclerosis
Lundberg, A. M., & Hansson, G. K. (2010) · Clinical Immunology · doi:10.1016/j.clim.2009.07.016 · Cited by 194
Infection and Atherosclerosis Development
Campbell, L. A., & Rosenfeld, M. E. (2015) · Archives of Medical Research · doi:10.1016/j.arcmed.2015.05.006 · Cited by 190
Safety of High Doses of Influenza Vaccine and Effect on Antibody Responses in Elderly Persons
Keitel, W. A., Atmar, R. L., Cate, T. R., Petersen, N. J., Greenberg, S. B., Ruben, F., & Couch, R. B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1121 · Cited by 187
“15 51 20 (16-25) 37 (30-45) 14 (11-19) 28 (21-37) 45 (31-65) 86 (63-118) 52 (34-80) 101 (70-146) 8 (6-10) 14 (11-18) 57 (44-73) 129 (95-175)”
Common infections and the risk of stroke
Grau, A. J., Urbanek, C., & Palm, F. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.163 · Cited by 188
Role of self-care in the patient with heart failure
Moser, D. K., Dickson, V., Jaarsma, T., Lee, C., Stromberg, A., & Riegel, B. (2012) · Current Cardiology Reports · doi:10.1007/s11886-012-0267-9 · Cited by 186
“Vaccinations, presumably by limiting infection, are associated with reductions in the risk of hospitalization and death among adults with HF [49].”
MOHAN, A., CHANDRA, S., AGARWAL, D., GULERIA, R., BROOR, S., GAUR, B., & PANDEY, R. M. (2010) · Respirology · doi:10.1111/j.1440-1843.2010.01722.x · Cited by 186
Hak, E. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.3.274 · Cited by 186
“Serious complications include pneumonia,(2,3) acute otitis media(4) and exacerbations of acute pulmonary,(5) cardiac, or cerebrovascular disease.(2,6,7) In the United States each”
Madjid, M., Naghavi, M., Litovsky, S., & Casscells, S. W. (2003) · Circulation · doi:10.1161/01.cir.0000102380.47012.92 · Cited by 177
Community influenza outbreaks and emergency department ambulance diversion
Schull, M. J., Mamdani, M. M., & Fang, J. (2004) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2003.12.008 · Cited by 173
Influenza Vaccination in Patients With Chronic Heart Failure
Vardeny, O., Claggett, B., Udell, J. A., Packer, M., Zile, M., Rouleau, J., Swedberg, K., Desai, A. S., Lefkowitz, M., Shi, V., et al. (2016) · JACC: Heart Failure · doi:10.1016/j.jchf.2015.10.012 · Cited by 161
“Nevertheless, other large, but more geographically homogenous, observational studies have shown associations between influenza vaccination and reduced risk for hospitalizations (22,23).”
BackgroundInfluenza‐Associated Mortality in Hong Kong
Wong, C., Chan, K., Hedley, A. J., & Peiris, J. S. M. (2004) · Clinical Infectious Diseases · doi:10.1086/425315 · Cited by 169
“of IHD [31–34], although other studies have failed to dem-”
BackgroundThe unmet need in the elderly: Designing new influenza vaccines for older adults
McElhaney, J. E. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.019 · Cited by 168
Clinical epidemiology of infectious disease among patients with chronic kidney disease
Ishigami, J., & Matsushita, K. (2019) · Clinical and Experimental Nephrology · doi:10.1007/s10157-018-1641-8 · Cited by 164
Jackson, M. L., Nelson, J. C., Weiss, N. S., Neuzil, K. M., Barlow, W., & Jackson, L. A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61160-5 · Cited by 163
Chow, E. J., Rolfes, M. A., O'Halloran, A., Anderson, E. J., Bennett, N. M., Billing, L., Chai, S., Dufort, E., Herlihy, R., Kim, S., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-1509 · Cited by 162
Influenza- and respiratory syncytial virus-associated mortality and hospitalisations
Jansen, A. G. S. C., Sanders, E. A. M., Hoes, A. W., van Loon, A. M., & Hak, E. (2007) · European Respiratory Journal · doi:10.1183/09031936.00034407 · Cited by 163
Nicolau, J. C., Feitosa, G. S., Petriz, J. L. F., Furtado, R. H. D. M., Précoma, D. B., Lemke, W., Lópes, R. D., Timerman, A., Marin‐Neto, J. A., Bezerra, L., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20210180 · Cited by 331
Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
Christenson, B., Hedlund, J., Lundbergh, P., & Örtqvist, Å. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00063504 · Cited by 162
“In a recent study by NICHOL et al. [ 29 ], influenza vaccination of elderly patients was associated with a reduction in the risk of hospitalisation for cardiac disease.”
BackgroundPlatelet Activation Is Associated With Myocardial Infarction in Patients With Pneumonia
Cangemi, R., Casciaro, M., Rossi, E., Calvieri, C., Bucci, T., Calabrese, C. M., Taliani, G., Falcone, M., Palange, P., Bertazzoni, G., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.07.985 · Cited by 159
“supported by studies indicating that influenza vaccination is associated with reduced risk for hospitalization for pneumonia, heart disease, cerebrovascular disease, and the risk for death from all causes during influenza seasons in elderly patients (3).”
BackgroundWijga, A. H. (2003) · Thorax · doi:10.1136/thorax.58.7.567 · Cited by 159
Mangtani, P., Cumberland, P., Hodgson, C. R., Roberts, J. A., Cutts, F. T., & Hall, A. J. (2004) · The Journal of Infectious Diseases · doi:10.1086/421274 · Cited by 159
“43%–53%) against death due to all causes [5].”
BackgroundInfluenza and cardiovascular disease: is there a causal relationship?
Madjid, M., Aboshady, I., Awan, I., Litovsky, S. H., & Casscells, S. W. (2004) · Europe PMC (PubMed Central) · Cited by 205
Influenza vaccine responses in older adults
McElhaney, J. E. (2011) · Ageing Research Reviews · doi:10.1016/j.arr.2010.10.008 · Cited by 155
Hung, I. F., Leung, A. Y. M., Chu, D. W., Leung, D. Y. P., Cheung, T. K. M., Chan, C. K., Lam, C. L. K., Liu, S., Chu, C., Ho, P., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/656587 · Cited by 155
“A previous study by Nichol et al [16] demonstrated that administration of TIV alone reduced the risk of hospitalization for cardiovascular and cerebrovascular diseases ( 16% and 19%, respectively).”
BackgroundAnnual Revaccination Against Influenza and Mortality Risk in Community-Dwelling Elderly Persons
Voordouw, A. C. G. (2004) · JAMA · doi:10.1001/jama.292.17.2089 · Cited by 148
Influenza-Associated Hospitalization in a Subtropical City
Wong, C. M., Yang, L., Chan, K. P., Leung, G. M., Chan, K. H., Guan, Y., Lam, T. H., Hedley, A. J., & Peiris, J. S. M. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030121 · Cited by 158
“Effects of influenza on cerebrovascular and ischemic heart disease may be partly explained by the acute pathophysiological responses triggered by influenza, which include changes in circulating clotting factors, platelet aggregation, and lysis, concentrations of inflammatory-response proteins, and alternations in cyto…”
BackgroundMaciosek, M. V., Solberg, L. I., Coffield, A. B., Edwards, N. M., & Goodman, M. J. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.03.008 · Cited by 170
Influenza Vaccination Is Associated With a Reduced Risk of Stroke
Grau, A. J., Fischer, B., Barth, C., Ling, P., Lichy, C., & Buggle, F. (2005) · Stroke · doi:10.1161/01.str.0000170674.45136.80 · Cited by 144
Madjid, M., Vela, D. C., Khalili-Tabrizi, H., Casscells, S. W., & Litovsky, S. H. (2007) · PubMed · Cited by 170
Seasonal influenza epidemiology in sub-Saharan Africa: a systematic review
Gessner, B. D., Shindo, N., & Briand, S. C. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70008-1 · Cited by 167
Non-Traditional Settings for Influenza Vaccination of Adults: Costs and Cost Effectiveness
Prosser, L. A., O’Brien, M. A., Molinari, N., Hohman, K. H., Nichol, K. L., Messonnier, M. L., & Lieu, T. A. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826020-00006 · Cited by 156
Self-citationThe Role of the Cerebral Capillaries in Acute Ischemic Stroke: The Extended Penumbra Model
Østergaard, L., Jespersen, S. N., Mouridsen, K., Mikkelsen, I. K., Jónsdóttir, K. Ý., Tietze, A., Blicher, J. U., Aamand, R., Hjort, N., Iversen, N., et al. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.18 · Cited by 157
Infection, vaccination, and childhood arterial ischemic stroke
Fullerton, H. J., Hills, N. K., Elkind, M. S. V., Dowling, M. M., Wintermark, M., Glaser, C. A., Tan, M. A., Rivkin, M. J., Titomanlio, L., Barkovich, A. J., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000002065 · Cited by 130
Gurfinkel, E. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)95374-7 · Cited by 130
Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.
Reber, A. J., Chirkova, T., Kim, J. H., Cao, W., Biber, R., Shay, D. K., & Sambhara, S. R. (2012) · Europe PMC (PubMed Central) · Cited by 151
Influenza control in the 21st century: Optimizing protection of older adults
Monto, A. S., Ansaldi, F., Aspinall, R., McElhaney, J. E., Montaño, L. F., Nichol, K. L., Puig‐Barberà, J., Schmitt, J., & Stephenson, I. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.032 · Cited by 136
“Influenza is also known to cause exacerbations of pulmonary and cardiovascular disease [4,7,31], and is the likely primary cause of the winter-season increase in mortality among patients with underlying chronic disease such as ischemic heart disease, stroke, diabetes, and pneumonia [32–34].”
InfluentialSelf-citationVaccine Preventable Diseases and Vaccination Coverage in Australia, 2003 to 2005
Brotherton, J. M. L., Wang, H., Schaffer, A. L., Quinn, H., Quinn, R., Hull, B. P., Lawrence, G. L., Wood, J., Wood, N., Rosewell, A. E., et al. (2007) · Communicable Diseases Intelligence · doi:10.33321/cdi-2007-31-25 · Cited by 139
Cardiovascular disease prevention
Van Camp, G. (2014) · Acta Clinica Belgica · doi:10.1179/2295333714y.0000000069 · Cited by 120
Immunomodulation of Atherosclerosis: Implications for Vaccine Development—ATVB In Focus
Nilsson, J., Hansson, G. K., & Shah, P. K. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000149142.42590.a2 · Cited by 122
Comparison of Performance of Traditional Medicare vs Medicare Managed Care
Landon, B. E. (2004) · JAMA · doi:10.1001/jama.291.14.1744 · Cited by 120
Influenza and Other Respiratory Viruses
Dumyati, G. K. (2006) · Infectious disease and therapy · doi:10.3109/9780203909447.013 · Cited by 118
Metadata
- Authors
- Nichol, K. L., Nordin, J., Mullooly, J., Lask, R., Fillbrandt, K., & Iwane, M.
- Affiliations
- University of Minnesota (US)
- HealthPartners (US)
- Kaiser Permanente (US)
- Centers for Disease Control and Prevention (US)
- ORCID
- Nordin, James
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-04-03
- Volume
- 348
- Issue
- 14
- Pages
- 1322-1332
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2116971894
- Cited by
- 752
- References
- 42
- Citations by year
- 2026: 12 · 2025: 20 · 2024: 10 · 2023: 15 · 2022: 14 · 2021: 17 · 2020: 23 · 2019: 26 · 2018: 29 · 2017: 25 · 2016: 19 · 2015: 33 · 2014: 29 · 2013: 42 · 2012: 50
- FWCI
- 45.37
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Keywords
- influenza vaccination, influenza, stroke, heart disease, hospitalization, older adults, pneumonia, mortality, ischemic heart disease, cerebrovascular disease, upper respiratory tract infection, managed care, community-dwelling older adults, vaccine effectiveness, dementia, comorbidities, subgroup analysis
- MeSH terms
- Aged, Aged, 80 and over, Female, Heart Diseases, Hospitalization, Humans, Influenza, Human, Influenza Vaccines, Male, Mortality, Pneumonia, Risk, Logistic Models, Odds Ratio, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.